Middlleboro, MA, United States of America

David M Breese


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Spotlight: David M. Breese**

Introduction

David M. Breese, an innovative inventor based in Middleboro, Massachusetts, has made significant contributions to the field of pharmaceuticals. With a focus on treating inflammation and pain, his work stands out in a landscape that constantly seeks effective solutions for these common medical issues.

Latest Patents

David M. Breese holds a patent for a groundbreaking method aimed at treating inflammation and pain. The patent details a pharmaceutical composition that includes a pharmaceutically acceptable carrier and either ω-(methylsulfonyl)alkylamine or ω-(methylsulfonyl)alkylamide. This invention provides a method for alleviating inflammatory conditions and related pain by administering these compounds to individuals in need. The innovative aspect of this patent lies in the potential effectiveness of these compounds in addressing inflammation-related disorders.

Career Highlights

Currently, David is associated with Olatec Therapeutics LLC, a company committed to advancing therapeutic solutions for various health challenges. His expertise and innovative mindset have allowed him to contribute valuable insights and developments in the field.

Collaborations

Throughout his career, David has collaborated with notable professionals, including Joseph St Laurent and Gerald S Jones. These partnerships highlight the collaborative spirit that drives innovation and the development of new therapeutic strategies.

Conclusion

David M. Breese's work exemplifies the importance of innovation in healthcare, particularly in developing effective treatments for inflammation and pain. His patent not only showcases his ingenuity as an inventor but also underscores the potential impact of his work on patients' lives. With a strong foundation in collaboration and a commitment to therapeutic advancement, David continues to make strides in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…